Combined nucleus pulposus augmentation and annulus fibrosus repair prevents acute intervertebral disc degeneration after discectomy.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
11 03 2020
Historique:
received: 06 08 2019
accepted: 10 02 2020
entrez: 13 3 2020
pubmed: 13 3 2020
medline: 24 6 2021
Statut: ppublish

Résumé

Tissue-engineered approaches for the treatment of early-stage intervertebral disc degeneration have shown promise in preclinical studies. However, none of these therapies has been approved for clinical use, in part because each therapy targets only one aspect of the intervertebral disc's composite structure. At present, there is no reliable method to prevent intervertebral disc degeneration after herniation and subsequent discectomy. Here, we demonstrate the prevention of degeneration and maintenance of mechanical function in the ovine lumbar spine after discectomy by combining strategies for nucleus pulposus augmentation using hyaluronic acid injection and repair of the annulus fibrosus using a photocrosslinked collagen patch. This combined approach healed annulus fibrosus defects, restored nucleus pulposus hydration, and maintained native torsional and compressive stiffness up to 6 weeks after injury. These data demonstrate the necessity of a combined strategy for arresting intervertebral disc degeneration and support further translation of combinatorial interventions to treat herniations in the human spine.

Identifiants

pubmed: 32161108
pii: 12/534/eaay2380
doi: 10.1126/scitranslmed.aay2380
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Stephen R Sloan (SR)

Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.

Christoph Wipplinger (C)

Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065, USA.

Sertaç Kirnaz (S)

Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065, USA.

Rodrigo Navarro-Ramirez (R)

Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065, USA.

Franziska Schmidt (F)

Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065, USA.

Duncan McCloskey (D)

Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.

Tania Pannellini (T)

Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY 10065, USA.

Antonella Schiavinato (A)

Fidia Farmaceutici S.p.A, Abano Terme, PD 35031, Italy.

Roger Härtl (R)

Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065, USA.

Lawrence J Bonassar (LJ)

Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA. lb244@cornell.edu.
Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH